1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Angiosarcoma: new trials by email Literature Review of Angiosarcoma trials Research Report on Angiosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A - Angiosarcoma | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2024-03-22 | 2026-02-13 |
Hemangiosarcoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Vascular Tissue (1) · Sarcoma (1)
Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Paclitaxel (1) · RNA, Messenger (1) · peginterferon alfa-2a (1)
M.D. Anderson Cancer Center (1)
Vinod Ravi, MD (1)